{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:29:48Z","timestamp":1792628988467,"version":"4.5.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-114530GA-I00"],"award-info":[{"award-number":["PID2020-114530GA-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021-124890OB-I00"],"award-info":[{"award-number":["PID2021-124890OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023561","name":"Ministerio de Universidades","doi-asserted-by":"publisher","award":["MS21-126"],"award-info":[{"award-number":["MS21-126"]}],"id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["CIACIF\/2022\/341"],"award-info":[{"award-number":["CIACIF\/2022\/341"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["331151"],"award-info":[{"award-number":["331151"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universitat de Valencia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Several drugs can be used for treating inflammatory skin pathologies like dermatitis and psoriasis. However, for the management of chronic and long-term cases, topical administration is preferred over oral delivery since it prevents certain issues due to systemic side effects from occurring. Cyclosporin A (CsA) has been used for this purpose; however, its high molecular weight (1202\u00a0Da) restricts the diffusion through the skin structure. Here, we developed a nano-in-micro device combining lipid vesicles (LVs) and dissolving microneedle array patches (DMAPs) for targeted skin delivery. CsA-LVs allowed the effective incorporation of CsA in the hydrophilic DMAP matrix despite the hydrophobicity of the drug. Polymeric matrix composed of poly (vinyl alcohol) (5% w\/v), poly (vinyl pyrrolidine) (15% w\/v) and CsA-LV dispersion (10% v\/v) led to the formation of CsA-LVs@DMAPs with adequate mechanical properties to penetrate the <jats:italic>stratum corneum<\/jats:italic> barrier. The safety and biocompatibility were ensured in an in vitro viability test using HaCaT keratinocytes and L929 fibroblast cell lines. Ex vivo permeability studies in a Franz-diffusion cell setup showed effective drug retention in the skin structure. Finally, CsA-LVs@DMAPs were challenged in an in vivo murine model of delayed-type hypersensitivity to corroborate their potential to ameliorate skin inflammatory conditions. Different findings like photon emission reduction in bioluminescence study, normalisation of histological damage and decrease of inflammatory cytokines point out the effectivity of CsA-LVs@DMAPs to treat these conditions. Overall, our study demonstrates that CsA-LVs@DMAPs can downregulate the skin inflammatory environment which paves the way for their clinical translation and their use as an alternative to corticosteroid-based therapies.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s13346-024-01542-9","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T20:03:56Z","timestamp":1710273836000},"page":"3404-3421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: Development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-6324","authenticated-orcid":false,"given":"Miquel","family":"Mart\u00ednez-Navarrete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8012-326X","authenticated-orcid":false,"given":"Antonio Jos\u00e9","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3606-7210","authenticated-orcid":false,"given":"Maria C.","family":"Lobita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1021-8703","authenticated-orcid":false,"given":"Mar\u00eda Carmen","family":"Recio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3613-8784","authenticated-orcid":false,"given":"Rosa","family":"Giner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5439-4568","authenticated-orcid":false,"given":"Juan","family":"Aparicio-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1801-311X","authenticated-orcid":false,"given":"Mar\u00eda Carmen","family":"Montesinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7850-6309","authenticated-orcid":false,"given":"H\u00e9lder A.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0126-414X","authenticated-orcid":false,"given":"Ana","family":"Melero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"1542_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000370220","volume":"66","author":"S Nutten","year":"2015","unstructured":"Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66:8\u201316.","journal-title":"Ann Nutr Metab"},{"key":"1542_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jid.2016.08.022","volume":"137","author":"PM Brunner","year":"2017","unstructured":"Brunner PM, Silverberg JI, Guttman-Yassky E, Paller AS, Kabashima K, Amagai M, et al. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Invest Dermatol. 2017;137:18\u201325.","journal-title":"J Invest Dermatol"},{"key":"1542_CR3","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jaci.2022.12.002","volume":"151","author":"JP Thyssen","year":"2023","unstructured":"Thyssen JP, Halling A-S, Schmid-Grendelmeier P, Guttman-Yassky E, Silverberg JI. Comorbidities of atopic dermatitis-what does the evidence say? J Allergy Clin Immunol. 2023;151:1155\u201362.","journal-title":"J Allergy Clin Immunol"},{"key":"1542_CR4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/all.14631","volume":"76","author":"D Siegels","year":"2021","unstructured":"Siegels D, Heratizadeh A, Abraham S, Binnmyr J, Brockow K, Irvine AD, et al. Systemic treatments in the management of atopic dermatitis: a systematic review and meta-analysis. Allergy Eur J Allergy Clin Immunol. 2021;76:1053\u201376.","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"1542_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jaip.2019.08.030","volume":"8","author":"Y Schonmann","year":"2020","unstructured":"Schonmann Y, Mansfield KE, Hayes JF, Abuabara K, Roberts A, Smeeth L, et al. Atopic eczema in adulthood and risk of depression and anxiety: a population-based cohort study. J Allergy Clin Immunol Pract. 2020;8:248\u2013257.e16.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1542_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1203475416685078","volume":"21","author":"MN Nicholas","year":"2017","unstructured":"Nicholas MN, Gooderham MJ. Atopic dermatitis, depression, and suicidality. J Cutan Med Surg. 2017;21:237\u201342.","journal-title":"J Cutan Med Surg"},{"key":"1542_CR7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s13555-021-00519-7","volume":"11","author":"F Toron","year":"2021","unstructured":"Toron F, Neary MP, Smith TW, Gruben D, Romero W, Cha A, et al. Clinical and economic burden of mild-to-moderate atopic dermatitis in the UK: a propensity-score-matched case-control study. Dermatol Ther (Heidelb). 2021;11:907\u201328.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1542_CR8","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jaad.2022.01.009","volume":"86","author":"DMR Davis","year":"2022","unstructured":"Davis DMR, Drucker AM, Alikhan A, Bercovitch L, Cohen DE, Darr JM, et al. American Academy of Dermatology guidelines: awareness of comorbidities associated with atopic dermatitis in adults. J Am Acad Dermatol. 2022;86:1335\u20131336.e18. https:\/\/doi.org\/10.1016\/j.jaad.2022.01.009.","journal-title":"J Am Acad Dermatol"},{"key":"1542_CR9","doi-asserted-by":"crossref","unstructured":"Eichenfield L, Tom W, Chamlin S, Feldman S, Hanifin J, Simpson E, et al. Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol [Internet]. 2014;71:116\u2013132. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962213010955.","DOI":"10.1016\/j.jaad.2014.03.023"},{"key":"1542_CR10","doi-asserted-by":"publisher","unstructured":"Siegfried EC, Jaworski JC, Kaiser JD, Hebert AA. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. BMC Pediatr. 2016;16:1\u201315. https:\/\/doi.org\/10.1186\/s12887-016-0607-9.","DOI":"10.1186\/s12887-016-0607-9"},{"key":"1542_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF02850199","volume":"20","author":"AKC Leung","year":"2003","unstructured":"Leung AKC, Barber KA. Managing childhood atopic dermatitis. Adv Ther. 2003;20:129\u201337.","journal-title":"Adv Ther"},{"issue":"Suppl","key":"1542_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/bjd.12976","volume":"170","author":"LF Eichenfield","year":"2014","unstructured":"Eichenfield LF, Totri C. Optimizing outcomes for paediatric atopic dermatitis. Br J Dermatol. 2014;170(Suppl):31\u20137.","journal-title":"Br J Dermatol"},{"key":"1542_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0738-081X(02)00368-1","volume":"21","author":"C Charman","year":"2003","unstructured":"Charman C, Williams H. The use of corticosteroids and corticosteroid phobia in atopic dermatitis. Clin Dermatol. 2003;21:193\u2013200.","journal-title":"Clin Dermatol"},{"key":"1542_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/adc.76.6.505","volume":"76","author":"L Patel","year":"1997","unstructured":"Patel L, Clayton PE, Jenney ME, Ferguson JE, David TJ. Adult height in patients with childhood onset atopic dermatitis. Arch Dis Child. 1997;76:505\u20138.","journal-title":"Arch Dis Child"},{"key":"1542_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","volume":"54","author":"UR Hengge","year":"2006","unstructured":"Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54:1\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"1542_CR16","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1001\/archinte.1976.03630050086014","volume":"136","author":"P May","year":"1976","unstructured":"May P, Stein EJ, Ryter RJ, Hirsh FS, Michel B, Levy RP. Cushing syndrome from percutaneous absorption of triamcinolone cream. Arch Intern Med. 1976;136:612\u20133.","journal-title":"Arch Intern Med"},{"key":"1542_CR17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.5694\/j.1326-5377.1971.tb87696.x","volume":"1","author":"JA Keipert","year":"1971","unstructured":"Keipert JA, Kelly R. Temporary Cushing\u2019s syndrome from percutaneous absorption of betamethasone 17-valerate. Med J Aust. 1971;1:542\u20134.","journal-title":"Med J Aust"},{"key":"1542_CR18","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1542\/peds.105.4.794","volume":"105","author":"JA Ellison","year":"2000","unstructured":"Ellison JA, Patel L, Ray DW, David TJ, Clayton PE. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics. 2000;105:794\u20139.","journal-title":"Pediatrics"},{"issue":"Suppl","key":"1542_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000257888","volume":"152","author":"DD Munro","year":"1976","unstructured":"Munro DD. Topical corticosteroid therapy and its effect on the hypothalamic-pituitary-adrenal axis. Dermatologica. 1976;152(Suppl):173\u201380.","journal-title":"Dermatologica"},{"key":"1542_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.anai.2020.08.016","volume":"126","author":"N Puar","year":"2021","unstructured":"Puar N, Chovatiya R, Paller AS. New treatments in atopic dermatitis. Ann Allergy Asthma Immunol. 2021;126:21\u201331. https:\/\/doi.org\/10.1016\/j.anai.2020.08.016.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1542_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000051694","volume":"203","author":"JI Harper","year":"2001","unstructured":"Harper JI, Berth-Jones J, Camp RDR, Dillon MJ, Finlay AY, Holden CA, et al. Cyclosporin for atopic dermatitis in children. Dermatology. 2001;203:3\u20136.","journal-title":"Dermatology"},{"key":"1542_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2133.1993.tb15154.x","volume":"128","author":"N Sepp","year":"1993","unstructured":"Sepp N, Fritsch PO. Can cyclosporin A induce permanent remission of atopic dermatitis? Br J Dermatol. 1993;128:213\u20136.","journal-title":"Br J Dermatol"},{"key":"1542_CR23","doi-asserted-by":"crossref","unstructured":"Couselo-Rodr\u00edguez C, Batalla A, Carrascosa JM, Chicharro P, Gonz\u00e1lez-Quesada A, de la Cueva P, et al. Supervivencia de la ciclosporina en el tratamiento de la dermatitis at\u00f3pica moderada-grave: Registro Espa\u00f1ol de Dermatitis At\u00f3pica (BIOBADATOP). Actas Dermo-Sifiliogr\u00e1ficas. 2023.","DOI":"10.1016\/j.ad.2023.07.014"},{"key":"1542_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1468-3083.2006.01877.x","volume":"21","author":"DJ Hijnen","year":"2007","unstructured":"Hijnen DJ, Ten Berge O, Timmer-de Mik L, Bruijnzeel-koomen CAFM, De Bruin-weller MS. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis. J Eur Acad Dermatol Venereol. 2007;21:85\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1542_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2310\/6620.2007.06025","volume":"18","author":"DJ Hijnen","year":"2007","unstructured":"Hijnen DJ, Knol E, Bruijnzeel-Koomen C, De Bruin-Weller M. Cyclosporin A treatment is associated with increased serum immunoglobulin E levels in a subgroup of atopic dermatitis patients. Dermatitis. 2007;18:163\u20135.","journal-title":"Dermatitis"},{"issue":"Suppl","key":"1542_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1365-2133.1990.tb02883.x","volume":"122","author":"G Feutren","year":"1990","unstructured":"Feutren G, Abeywickrama K, Friend D, von Graffenried B. Renal function and blood pressure in psoriatic patients treated with cyclosporin A. Br J Dermatol. 1990;122(Suppl):57\u201369.","journal-title":"Br J Dermatol"},{"key":"1542_CR27","doi-asserted-by":"crossref","unstructured":"Alkilani AZ, McCrudden MTC, Donnelly RF. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7:438\u201370.","DOI":"10.3390\/pharmaceutics7040438"},{"key":"1542_CR28","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/wnan.147","volume":"3","author":"J Torin Huzil","year":"2011","unstructured":"Torin Huzil J, Sivaloganathan S, Kohandel M, Foldvari M. Drug delivery through the skin: molecular simulations of barrier lipids to design more effective noninvasive dermal and transdermal delivery systems for small molecules, biologics, and cosmetics. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011;3:449\u201362.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"1542_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.bbalip.2013.11.006","volume":"1841","author":"J van Smeden","year":"2014","unstructured":"van Smeden J, Janssens M, Gooris GS, Bouwstra JA. The important role of stratum corneum lipids for the cutaneous barrier function. Biochim Biophys Acta Mol Cell Biol Lipids. 2014;1841:295\u2013313. https:\/\/doi.org\/10.1016\/j.bbalip.2013.11.006.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"1542_CR30","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/jphp.12334","volume":"67","author":"A Herman","year":"2015","unstructured":"Herman A, Herman AP. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review. J Pharm Pharmacol. 2015;67:473\u201385.","journal-title":"J Pharm Pharmacol"},{"key":"1542_CR31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1517\/17425247.2014.885501","volume":"11","author":"C-H Lin","year":"2014","unstructured":"Lin C-H, Aljuffali IA, Fang J-Y. Lasers as an approach for promoting drug delivery via skin. Expert Opin Drug Deliv. 2014;11:599\u2013614.","journal-title":"Expert Opin Drug Deliv"},{"key":"1542_CR32","unstructured":"Aguillera Forte ALS, Melero A, Ruver Beck RC, Lehr C-M. Polyester particles for drug delivery to the skin: local and systemic applications [Internet]. Handbook of Polyester Drug Delivery Systems. 2016. Available from: https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-85009661098&doi=10.4032%2F9789814669665&partnerID=40&md5=09bb105a350d4973355586d2fb12dff8."},{"key":"1542_CR33","unstructured":"Carreras JJ, Tapia-Ramirez WE, Sala A, Guillot AJ, Garrigues TM, Melero A. Ultraflexible lipid vesicles allow topical absorption of cyclosporin A. Drug Deliv Transl Res [Internet]. 2020;10:486\u201397. Available from: https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-85076852834&doi=10.1007%2Fs13346-019-00693-4&partnerID=40&md5=f9172a4bc884ce04877f444e46b06515."},{"key":"1542_CR34","doi-asserted-by":"crossref","unstructured":"Guillot AJ, Mart\u00ednez-Navarrete M, Garrigues TM, Melero A. Skin drug delivery using lipid vesicles: a starting guideline for their development.\u00a0J Control Release\u00a0[Internet]. 2023;355:624\u201354. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0168365923001001.","DOI":"10.1016\/j.jconrel.2023.02.006"},{"key":"1542_CR35","unstructured":"Guillot AJ, Jornet-Moll\u00e1 E, Landsberg N, Mili\u00e1n-Guimer\u00e1 C, Montesinos MC, Garrigues TM, et al. Cyanocobalamin ultraflexible lipid vesicles: characterization and in vitro evaluation of drug-skin depth profiles. Pharmaceutics [Internet]. 2021;13. Available from: https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-85103107711&doi=10.3390%2Fpharmaceutics13030418&partnerID=40&md5=e90e2c7352c8558ce85b51c28dle7242."},{"key":"1542_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146514","volume":"11","author":"J Dreier","year":"2016","unstructured":"Dreier J, S\u00f8rensen JA, Brewer JR. Superresolution and fluorescence dynamics evidence reveal That Intact Liposomes Do Not Cross the Human Skin Barrier. PLoS ONE. 2016;11: e0146514.","journal-title":"PLoS ONE"},{"key":"1542_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-chembioeng-060816-101514","volume":"8","author":"MR Prausnitz","year":"2017","unstructured":"Prausnitz MR. Engineering microneedle patches for vaccination and drug delivery to skin. Annu Rev Chem Biomol Eng. 2017;8:177\u2013200.","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"1542_CR38","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.jpcs.2007.10.059","volume":"69","author":"HS Gill","year":"2008","unstructured":"Gill HS, Prausnitz MR. Pocketed microneedles for drug delivery to the skin. J Phys Chem Solids. 2008;69:1537\u201341.","journal-title":"J Phys Chem Solids"},{"key":"1542_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/1061186X.2016.1200589","volume":"25","author":"H-R Jeong","year":"2017","unstructured":"Jeong H-R, Lee H-S, Choi I-J, Park J-H. Considerations in the use of microneedles: pain, convenience, anxiety and safety. J Drug Target. 2017;25:29\u201340.","journal-title":"J Drug Target"},{"key":"1542_CR40","doi-asserted-by":"crossref","unstructured":"Guillot AJ, Mart\u00ednez-Navarrete M, Zinchuk-Mironova V, Melero A. Microneedle-assisted transdermal delivery of nanoparticles: recent insights and prospects. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023;15:e1884.","DOI":"10.1002\/wnan.1884"},{"key":"1542_CR41","unstructured":"Guillot AJ, Cordeiro AS, Donnelly RF, Montesinos MC, Garrigues TM, Melero A. Microneedle\u2010based delivery: an overview of current applications and trends. Pharmaceutics [Internet]. 2020;12:1\u201328. Available from: https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-85088612073&doi=10.3390%2Fpharmaceutics12060569&partnerID=40&md5=b3be60c4eb32101d13493d0232921b11."},{"key":"1542_CR42","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1166\/jbn.2017.2474","volume":"13","author":"Y Hao","year":"2017","unstructured":"Hao Y, Li W, Zhou X, Yang F, Qian Z. Microneedles-based transdermal drug delivery systems: a review. J Biomed Nanotechnol. 2017;13:1581\u201397.","journal-title":"J Biomed Nanotechnol"},{"key":"1542_CR43","doi-asserted-by":"crossref","unstructured":"Chen X, Wang L, Yu H, Li C, Feng J, Haq F, et al. Preparation, properties and challenges of the microneedles-based insulin delivery system.\u00a0J Control Release\u00a0[Internet]. 2018;288:173\u201388. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0168365918305169.","DOI":"10.1016\/j.jconrel.2018.08.042"},{"key":"1542_CR44","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/gt.2010.22","volume":"17","author":"HS Gill","year":"2010","unstructured":"Gill HS, S\u00f6derholm J, Prausnitz MR, S\u00e4llberg M. Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine. Gene Ther. 2010;17:811\u20134.","journal-title":"Gene Ther"},{"key":"1542_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004773","volume":"4","author":"DG Koutsonanos","year":"2009","unstructured":"Koutsonanos DG, del Pilar MM, Zarnitsyn VG, Sullivan SP, Compans RW, Prausnitz MR, et al. Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS ONE. 2009;4: e4773.","journal-title":"PLoS ONE"},{"key":"1542_CR46","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1016\/j.biomaterials.2012.12.041","volume":"34","author":"M-C Chen","year":"2013","unstructured":"Chen M-C, Huang S-F, Lai K-Y, Ling M-H. Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination. Biomaterials. 2013;34:3077\u201386.","journal-title":"Biomaterials"},{"key":"1542_CR47","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s13346-021-01077-3","volume":"12","author":"J Zhao","year":"2022","unstructured":"Zhao J, Xu G, Yao X, Zhou H, Lyu B, Pei S, et al. Microneedle-based insulin transdermal delivery system: current status and translation challenges. Drug Deliv Transl Res. 2022;12:2403\u201327. https:\/\/doi.org\/10.1007\/s13346-021-01077-3.","journal-title":"Drug Deliv Transl Res"},{"key":"1542_CR48","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1039\/D0TB02133D","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wu M, Tan D, Liu Q, Xia R, Chen M, et al. A dissolving and glucose-responsive insulin-releasing microneedle patch for type 1 diabetes therapy. J Mater Chem B. 2021;9:648\u201357.","journal-title":"J Mater Chem B"},{"key":"1542_CR49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.msec.2018.04.055","volume":"90","author":"D Liu","year":"2018","unstructured":"Liu D, Yu B, Jiang G, Yu W, Zhang Y, Xu B. Fabrication of composite microneedles integrated with insulin-loaded CaCO3 microparticles and PVP for transdermal delivery in diabetic rats. Mater Sci Eng, C. 2018;90:180\u20138.","journal-title":"Mater Sci Eng, C"},{"key":"1542_CR50","doi-asserted-by":"crossref","unstructured":"Qin W, Quan G, Sun Y, Chen M, Yang P, Feng D, et al. Theranostics dissolving microneedles with spatiotemporally controlled pulsatile release nanosystem for synergistic chemo-photothermal therapy of melanoma. Theranostics. 2020;10:8179\u201396.","DOI":"10.7150\/thno.44194"},{"key":"1542_CR51","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41551-018-0337-4","volume":"3","author":"W Li","year":"2019","unstructured":"Li W, Terry RN, Tang J, Feng MR, Schwendeman SP, Prausnitz MR. Rapidly separable microneedle patch for the sustained release of a contraceptive. Nat Biomed Eng. 2019;3:220\u20139.","journal-title":"Nat Biomed Eng"},{"key":"1542_CR52","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jconrel.2022.04.051","volume":"347","author":"W Li","year":"2022","unstructured":"Li W, Chen JY, Terry RN, Tang J, Romanyuk A, Schwendeman SP, et al. Core-shell microneedle patch for six-month controlled-release contraceptive delivery. J Control Release. 2022;347:489\u201399.","journal-title":"J Control Release"},{"key":"1542_CR53","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/10826070500452010","volume":"29","author":"S-G-R Park","year":"2006","unstructured":"Park S-G-R, DKSC, Shim C,. A simple HPLC method for the determination of cyclosporin A in human whole blood. J Liq Chromatogr Relat Technol. 2006;29:391\u2013401. https:\/\/doi.org\/10.1080\/10826070500452010.","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"1542_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/765426","volume":"2014","author":"B Sabeti","year":"2014","unstructured":"Sabeti B, Noordin MI, Mohd S, Hashim R, Dahlan A, Javar HA. Development and characterization of liposomal doxorubicin hydrochloride with palm oil. Biomed Res Int. 2014;2014: 765426.","journal-title":"Biomed Res Int"},{"key":"1542_CR55","first-page":"101","volume":"5","author":"P Panwar","year":"2010","unstructured":"Panwar P, Pandey B, Lakhera PC, Singh KP. Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. Int J Nanomedicine. 2010;5:101\u20138.","journal-title":"Int J Nanomedicine"},{"key":"1542_CR56","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/BF02531316","volume":"5","author":"G Rouser","year":"1970","unstructured":"Rouser G, Fkeischer S, Yamamoto A. Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids. 1970;5:494\u20136.","journal-title":"Lipids"},{"key":"1542_CR57","doi-asserted-by":"crossref","unstructured":"Th\u00e9ry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current protocols in cell biology. United States 2006. pp 3.22.1-3.22.29.","DOI":"10.1002\/0471143030.cb0322s30"},{"key":"1542_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12317","volume":"12","author":"CM S\u00e1nchez-L\u00f3pez","year":"2023","unstructured":"S\u00e1nchez-L\u00f3pez CM, Gonz\u00e1lez-Arce A, Soler C, Ram\u00edrez-Toledo V, Trelis M, Bernal D, et al. Extracellular vesicles from the trematodes Fasciola hepatica and Dicrocoelium dendriticum trigger different responses in human THP-1 macrophages. J Extracell Vesicles. 2023;12: e12317.","journal-title":"J Extracell Vesicles"},{"key":"1542_CR59","doi-asserted-by":"crossref","unstructured":"Permana AD, Tekko IA, McCrudden MTC, Anjani QK, Ramadon D, McCarthy HO, et al. Solid lipid nanoparticle-based dissolving microneedles: a promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis.\u00a0J Control Release\u00a0[Internet]. 2019;316:34\u201352. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0168365919305735.","DOI":"10.1016\/j.jconrel.2019.10.004"},{"key":"1542_CR60","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10973-006-7846-1","volume":"87","author":"J Sab\u00edn","year":"2007","unstructured":"Sab\u00edn J, Prieto X, Sennato S, Blanco E, Messina P, Ruso J, et al. Examinationof the influence of F6H10 fluorinated diblocks on DPPC liposomes. J Therm Anal Calorim. 2007;87:301\u20134.","journal-title":"J Therm Anal Calorim"},{"key":"1542_CR61","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijpharm.2015.11.038","volume":"497","author":"E Larra\u00f1eta","year":"2016","unstructured":"Larra\u00f1eta E, Stewart S, Fallows SJ, Birkh\u00e4uer LL, McCrudden MTC, Woolfson AD, et al. A facile system to evaluate in vitro drug release from dissolving microneedle arrays. Int J Pharm. 2016;497:62\u20139.","journal-title":"Int J Pharm"},{"key":"1542_CR62","doi-asserted-by":"crossref","unstructured":"Larra\u00f1eta E, Moore J, Vicente-P\u00e9rez EM, Gonz\u00e1lez-V\u00e1zquez P, Lutton R, Woolfson AD, et al. A proposed model membrane and test method for microneedle insertion studies. Int J Pharm [Internet]. 2014;472:65\u201373. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0378517314003895.","DOI":"10.1016\/j.ijpharm.2014.05.042"},{"key":"1542_CR63","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11095-010-0169-8","volume":"28","author":"RF Donnelly","year":"2011","unstructured":"Donnelly RF, Majithiya R, Singh TRR, Morrow DIJ, Garland MJ, Demir YK, et al. Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharm Res. 2011;28:41\u201357.","journal-title":"Pharm Res"},{"key":"1542_CR64","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s004030050461","volume":"291","author":"K Kehe","year":"1999","unstructured":"Kehe K, Abend M, Kehe K, Ridi R, Peter RU, Van Beuningen D. Tissue engineering with HaCaT cells and a fibroblast cell line. Arch Dermatol Res. 1999;291:600\u20135.","journal-title":"Arch Dermatol Res"},{"key":"1542_CR65","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1177\/0391398818775519","volume":"41","author":"A Idrees","year":"2018","unstructured":"Idrees A, Chiono V, Ciardelli G, Shah S, Viebahn R, Zhang X, et al. Validation of in vitro assays in three-dimensional human dermal constructs. Int J Artif Organs. 2018;41:779\u201388.","journal-title":"Int J Artif Organs"},{"key":"1542_CR66","first-page":"1","volume":"6","author":"C D\u2019Amico","year":"2023","unstructured":"D\u2019Amico C, Fontana F, El-Sayed N, Elbadri K, Correia A, Rahikkala A, et al. Double-layered polyvinylpyrrolidone\u2013poly(methyl vinyl ether-alt-maleic acid)-based microneedles to deliver meloxicam: an in vitro, in vivo, and short-term stability evaluation study. Adv Ther (Weinh). 2023;6:1\u201310.","journal-title":"Adv Ther (Weinh)"},{"key":"1542_CR67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jdermsci.2018.04.013","volume":"91","author":"MCJ Hofmann","year":"2018","unstructured":"Hofmann MCJ, Schmidt M, Arne O, Geisslinger G, Parnham MJ, de Bruin NMWJ. Non-invasive bioluminescence imaging as a standardized assessment measure in mouse models of dermal inflammation. J Dermatol Sci. 2018;91:153\u201363. https:\/\/doi.org\/10.1016\/j.jdermsci.2018.04.013.","journal-title":"J Dermatol Sci"},{"key":"1542_CR68","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ijpharm.2019.05.066","volume":"566","author":"IK Ram\u00f6ller","year":"2019","unstructured":"Ram\u00f6ller IK, Tekko IA, McCarthy HO, Donnelly RF. Rapidly dissolving bilayer microneedle arrays \u2013 a minimally invasive transdermal drug delivery system for vitamin B12. Int J Pharm. 2019;566:299\u2013306. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.05.066.","journal-title":"Int J Pharm"},{"key":"1542_CR69","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"},{"key":"1542_CR70","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/exd.12461","volume":"23","author":"J Arasa","year":"2014","unstructured":"Arasa J, Martos P, Terencio MC, Valcuende-Cavero F, Montesinos MC. Topical application of the adenosine A2A receptor agonist CGS-21680 prevents phorbol-induced epidermal hyperplasia and inflammation in mice. Exp Dermatol. 2014;23:555\u201360.","journal-title":"Exp Dermatol"},{"key":"1542_CR71","first-page":"1","volume":"33","author":"H Han","year":"2023","unstructured":"Han H, Chen J, Li J, Correia A, B\u00e1rtolo R, Shahbazi MA, et al. Enhancing apoptosome assembly via mito-biomimetic lipid nanocarrier for cancer therapy. Adv Funct Mater. 2023;33:1\u201311.","journal-title":"Adv Funct Mater"},{"key":"1542_CR72","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/jmicro\/dfp056","volume":"59","author":"T Kodama","year":"2010","unstructured":"Kodama T, Tomita N, Horie S, Sax N, Iwasaki H, Suzuki R, et al. Morphological study of acoustic liposomes using transmission electron microscopy. J Electron Microsc (Tokyo). 2010;59:187\u201396.","journal-title":"J Electron Microsc (Tokyo)"},{"key":"1542_CR73","doi-asserted-by":"crossref","unstructured":"Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10:1\u201317.","DOI":"10.3390\/pharmaceutics10020057"},{"key":"1542_CR74","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0378-5173(03)00183-2","volume":"258","author":"DD Verma","year":"2003","unstructured":"Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm. 2003;258:141\u201351.","journal-title":"Int J Pharm"},{"key":"1542_CR75","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3389\/fphar.2015.00219","volume":"6","author":"S Hua","year":"2015","unstructured":"Hua S. Lipid-based nano-delivery systems for skin delivery of drugs and bioactives. Front Pharmacol. 2015;6:219.","journal-title":"Front Pharmacol"},{"key":"1542_CR76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/08982104.2015.1022556","volume":"26","author":"A Hinna","year":"2016","unstructured":"Hinna A, Steiniger F, Hupfeld S, Stein P, Kuntsche J, Brandl M. Filter-extruded liposomes revisited: a study into size distributions and morphologies in relation to lipid-composition and process parameters. J Liposome Res. 2016;26:11\u201320.","journal-title":"J Liposome Res"},{"key":"1542_CR77","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1006\/jcis.2002.8432","volume":"251","author":"DG Fatouros","year":"2002","unstructured":"Fatouros DG, Antimisiaris SG. Effect of amphiphilic drugs on the stability and zeta-potential of their liposome formulations: a study with prednisolone, diazepam, and griseofulvin. J Colloid Interface Sci. 2002;251:271\u20137.","journal-title":"J Colloid Interface Sci"},{"key":"1542_CR78","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/134876","volume":"2012","author":"M Badran","year":"2012","unstructured":"Badran M, Shalaby K, Al-Omrani A. Influence of the flexible liposomes on the skin deposition of a hydrophilic model drug, carboxyfluorescein: dependency on their composition. ScientificWorldJournal. 2012;2012: 134876.","journal-title":"ScientificWorldJournal"},{"key":"1542_CR79","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s10450-016-9767-z","volume":"22","author":"E Chibowski","year":"2016","unstructured":"Chibowski E, Szcze\u015b A. Zeta potential and surface charge of DPPC and DOPC liposomes in the presence of PLC enzyme. Adsorption. 2016;22:755\u201365.","journal-title":"Adsorption"},{"key":"1542_CR80","first-page":"255","volume":"12","author":"S Honary","year":"2013","unstructured":"Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems - a review (Part 1). Trop J Pharm Res. 2013;12:255\u201364.","journal-title":"Trop J Pharm Res"},{"key":"1542_CR81","doi-asserted-by":"crossref","unstructured":"Kaushik S, Hord AH, Denson DD, McAllister D V, Smitra S, Allen MG, et al. Lack of pain associated with microfabricated microneedles. Anesth Analg [Internet]. 2001;92. Available from: https:\/\/journals.lww.com\/anesthesia-analgesia\/fulltext\/2001\/02000\/lack_of_pain_associated_with_microfabricated.41.aspx.","DOI":"10.1213\/00000539-200102000-00041"},{"key":"1542_CR82","doi-asserted-by":"crossref","unstructured":"Salwa, Chevala NT, Jitta SR, Marques SM, Vaz VM, Kumar L. Polymeric microneedles for transdermal delivery of nanoparticles: frontiers of formulation, sterility and stability aspects. J Drug Deliv Sci Technol [Internet]. 2021;65:102711. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1773224721003919.","DOI":"10.1016\/j.jddst.2021.102711"},{"key":"1542_CR83","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.1039\/C6RA27476E","volume":"7","author":"IC Lee","year":"2017","unstructured":"Lee IC, Wu YC, Tsai SW, Chen CH, Wu MH. Fabrication of two-layer dissolving polyvinylpyrrolidone microneedles with different molecular weights for in vivo insulin transdermal delivery. RSC Adv. 2017;7:5067\u201375. https:\/\/doi.org\/10.1039\/C6RA27476E.","journal-title":"RSC Adv"},{"key":"1542_CR84","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.tiv.2008.06.015","volume":"22","author":"RS Ray","year":"2008","unstructured":"Ray RS, Agrawal N, Sharma A, Hans RK. Use of L-929 cell line for phototoxicity assessment. Toxicol In Vitro. 2008;22:1775\u201381.","journal-title":"Toxicol In Vitro"},{"key":"1542_CR85","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/978-3-642-77817-9_38","volume-title":"Cell and Tissue Culture Models in Dermatological Research","author":"A Hoh","year":"1993","unstructured":"Hoh A, Maier K. Comparative cytotoxicity test with human keratinocytes, HaCaT cells, and skin fibroblasts to investigate skin-irritating substances. In: Bernd A, Bereiter-Hahn J, Hevert F, Holzmann H, editors. Cell and Tissue Culture Models in Dermatological Research. Springer, Berlin Heidelberg: Berlin, Heidelberg; 1993. p. 341\u20137."},{"key":"1542_CR86","doi-asserted-by":"crossref","unstructured":"Zhang XP, Wang BB, Li WX, Fei WM, Cui Y, Guo XD. In vivo safety assessment, biodistribution and toxicology of polyvinyl alcohol microneedles with 160-day uninterruptedly applications in mice. European Journal of Pharmaceutics and Biopharmaceutics [Internet]. 2021;160:1\u20138. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0939641121000114.","DOI":"10.1016\/j.ejpb.2021.01.005"},{"key":"1542_CR87","doi-asserted-by":"crossref","unstructured":"Franco P, De Marco I. The use of Poly(N-vinyl pyrrolidone) in the delivery of drugs: a review. Polymers. 2020;12:1114.","DOI":"10.3390\/polym12051114"},{"key":"1542_CR88","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1002\/jps.21485","volume":"98","author":"H Liu","year":"2009","unstructured":"Liu H, Wang Y, Lang Y, Yao H, Dong Y, Li S. Bicontinuous cyclosporin a loaded water-AOT\/Tween 85-isopropylmyristate microemulsion: structural characterization and dermal pharmacokinetics in vivo. J Pharm Sci. 2009;98:1167\u201376.","journal-title":"J Pharm Sci"},{"key":"1542_CR89","doi-asserted-by":"crossref","unstructured":"Silva MI, Barbosa AI, Lima SAC, Costa P, Torres T, Reis S. Freeze-dried softisan\u00ae 649-based lipid nanoparticles for enhanced skin delivery of cyclosporine a. Nanomaterials. 2020;10:986.","DOI":"10.3390\/nano10050986"},{"key":"1542_CR90","doi-asserted-by":"crossref","unstructured":"Essaghraoui A, Belfkira A, Hamdaoui B, Nunes C, Lima SAC, Reis S. Improved dermal delivery of cyclosporine a loaded in solid lipid nanoparticles. Nanomaterials. 2019;9:1204.","DOI":"10.3390\/nano9091204"},{"key":"1542_CR91","doi-asserted-by":"crossref","unstructured":"Wairkar S, Patel D, Singh A. Nanostructured lipid carrier based dermal gel of cyclosporine for atopic dermatitis-in vitro and in vivo evaluation. J Drug Deliv Sci Technol [Internet]. 2022;72:103365. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1773224722002751.","DOI":"10.1016\/j.jddst.2022.103365"},{"key":"1542_CR92","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ejpb.2022.06.015","volume":"177","author":"AJ Guillot","year":"2022","unstructured":"Guillot AJ, Merino-Guti\u00e9rrez P, Bocchino A, O\u2019Mahony C, Giner RM, Recio MC, et al. Exploration of microneedle-assisted skin delivery of cyanocobalamin formulated in ultraflexible lipid vesicles. Eur J Pharm Biopharm. 2022;177:184\u201398.","journal-title":"Eur J Pharm Biopharm"},{"key":"1542_CR93","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1208\/s12249-010-9522-9","volume":"11","author":"S-F Ng","year":"2010","unstructured":"Ng S-F, Rouse JJ, Sanderson FD, Meidan V, Eccleston GM. Validation of a static franz diffusion cell system for in vitro permeation studies. AAPS PharmSciTech. 2010;11:1432\u201341. https:\/\/doi.org\/10.1208\/s12249-010-9522-9.","journal-title":"AAPS PharmSciTech"},{"key":"1542_CR94","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jinorgbio.2012.02.013","volume":"110","author":"A Pineau","year":"2012","unstructured":"Pineau A, Guillard O, Fauconneau B, Favreau F, Marty MH, Gaudin A, et al. In vitro study of percutaneous absorption of aluminum from antiperspirants through human skin in the FranzTM diffusion cell. J Inorg Biochem. 2012;110:21\u20136. https:\/\/doi.org\/10.1016\/j.jinorgbio.2012.02.013.","journal-title":"J Inorg Biochem"},{"key":"1542_CR95","doi-asserted-by":"publisher","first-page":"218","DOI":"10.18433\/J3WS33","volume":"13","author":"B Baert","year":"2010","unstructured":"Baert B, Boonen J, Burvenich C, Roche N, Stillaert F, Blondeel P, et al. A new discriminative criterion for the development of franz diffusion tests for transdermal pharmaceuticals. J Pharm Pharm Sci. 2010;13:218\u201330.","journal-title":"J Pharm Pharm Sci"},{"key":"1542_CR96","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s11095-017-2097-3","volume":"34","author":"JH Kang","year":"2017","unstructured":"Kang JH, Jang WY, Ko YT. The effect of surface charges on the cellular uptake of liposomes investigated by live cell imaging. Pharm Res. 2017;34:704\u201317.","journal-title":"Pharm Res"},{"key":"1542_CR97","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1172\/JCI28034","volume":"117","author":"JP Tuckermann","year":"2007","unstructured":"Tuckermann JP, Kleiman A, Moriggl R, Spanbroek R, Neumann A, Illing A, et al. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest. 2007;117:1381\u201390.","journal-title":"J Clin Invest"},{"key":"1542_CR98","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nm.1886","volume":"15","author":"S Gross","year":"2009","unstructured":"Gross S, Gammon ST, Moss BL, Rauch D, Harding J, Heinecke JW, et al. Bioluminescence imaging of myeloperoxidase activity in vivo. Nat Med. 2009;15:455\u201361.","journal-title":"Nat Med"},{"key":"1542_CR99","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20130062","volume":"212","author":"FC Weber","year":"2015","unstructured":"Weber FC, N\u00e9meth T, Csepregi JZ, Dudeck A, Roers A, Ozsv\u00e1ri B, et al. Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity. J Exp Med. 2015;212:15\u201322.","journal-title":"J Exp Med"},{"key":"1542_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.608871","volume":"11","author":"A Strzepa","year":"2020","unstructured":"Strzepa A, Gurski CJ, Dittel LJ, Szczepanik M, Pritchard KAJ, Dittel BN. Neutrophil-derived myeloperoxidase facilitates both the induction and elicitation phases of contact hypersensitivity. Front Immunol. 2020;11: 608871.","journal-title":"Front Immunol"},{"key":"1542_CR101","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ejpb.2017.04.029","volume":"117","author":"EM Vicente-Perez","year":"2017","unstructured":"Vicente-Perez EM, Larra\u00f1eta E, McCrudden MTC, Kissenpfennig A, Hegarty S, McCarthy HO, et al. Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo. Eur J Pharm Biopharm. 2017;117:400\u20137.","journal-title":"Eur J Pharm Biopharm"},{"key":"1542_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2021.682414","volume":"9","author":"K Pfisterer","year":"2021","unstructured":"Pfisterer K, Shaw LE, Symmank D, Weninger W. The extracellular matrix in skin inflammation and infection. Front Cell Dev Biol. 2021;9:1\u201319.","journal-title":"Front Cell Dev Biol"},{"key":"1542_CR103","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ptr.2309","volume":"22","author":"JM Prieto","year":"2008","unstructured":"Prieto JM, Recio MC, Giner RM, Schinella GR, M\u00e1\u00f1ez S, R\u00edos JL. In vitro and in vivo effects of Ranunculus peltatus subsp. baudotii methanol extract on models of eicosanoid production and contact dermatitis. Phytother Res. 2008;22:297\u2013302.","journal-title":"Phytother Res"},{"key":"1542_CR104","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1046\/j.1365-2133.2002.04949.x","volume":"147","author":"Y Oishi","year":"2002","unstructured":"Oishi Y, Fu ZW, Ohnuki Y, Kato H, Noguchi T. Molecular basis of the alteration in skin collagen metabolism in response to in vivo dexamethasone treatment: effects on the synthesis of collagen type I and III, collagenase, and tissue inhibitors of metalloproteinases. Br J Dermatol. 2002;147:859\u201368.","journal-title":"Br J Dermatol"},{"key":"1542_CR105","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/cod.13955","volume":"85","author":"K Yeung","year":"2021","unstructured":"Yeung K, Mraz V, Geisler C, Skov L, Bonefeld CM. The role of interleukin-1\u03b2 in the immune response to contact allergens. Contact Dermatitis. 2021;85:387\u201397.","journal-title":"Contact Dermatitis"},{"key":"1542_CR106","doi-asserted-by":"crossref","unstructured":"Luckett-Chastain LR, Calhoun KN, Schartz TR, Gallucci RM. IL-6 influences the balance between M1 and M2 macrophages in a mouse model of irritant contact dermatitis. The Journal of Immunology [Internet]. 2016; Available from: https:\/\/api.semanticscholar.org\/CorpusID:90935756.","DOI":"10.4049\/jimmunol.196.Supp.196.17"},{"key":"1542_CR107","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jdermsci.2022.05.006","volume":"107","author":"R Xiang","year":"2022","unstructured":"Xiang R, Hu L, Li S, Wei Z, Song Z, Chen Z, et al. Tiamulin inhibits TNF-\u03b1 and alleviates psoriasis-like dermatitis. J Dermatol Sci. 2022;107:32\u201340.","journal-title":"J Dermatol Sci"},{"key":"1542_CR108","doi-asserted-by":"crossref","unstructured":"Kim K, Kim H, Sung GY. An Interleukin-4 and Interleukin-13 induced atopic dermatitis human skin equivalent model by a skin-on-a-chip. Int J Mol Sci. 2022;23:2116.","DOI":"10.3390\/ijms23042116"},{"key":"1542_CR109","doi-asserted-by":"publisher","unstructured":"vander Straeten A, Sarmadi M, Daristotle JL, Kanelli M, Tostanoski LH, Collins J, et al. A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines. Nat Biotechnol. 2023.\u00a0https:\/\/doi.org\/10.1038\/s41587-023-01774-z.","DOI":"10.1038\/s41587-023-01774-z"},{"key":"1542_CR110","doi-asserted-by":"crossref","unstructured":"Avcil M, \u00c7elik A. Microneedles in drug delivery: progress and challenges. Micromachines (Basel). 2021;12. https:\/\/www.mdpi.com\/2072-666X\/12\/11\/1321.","DOI":"10.3390\/mi12111321"},{"key":"1542_CR111","doi-asserted-by":"crossref","unstructured":"Bui VD, Son S, Xavier W, Nguyen VQ, Jung JM, Lee J, et al. Dissolving microneedles for long-term storage and transdermal delivery of extracellular vesicles. Biomaterials. 2022;287:121644. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0142961222002848.","DOI":"10.1016\/j.biomaterials.2022.121644"},{"key":"1542_CR112","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1080\/17425247.2018.1522301","volume":"15","author":"AM Rodgers","year":"2018","unstructured":"Rodgers AM, Courtenay AJ, Donnelly RF. Dissolving microneedles for intradermal vaccination: manufacture, formulation, and stakeholder considerations. Expert Opin Drug Deliv. 2018;15:1039\u201343. https:\/\/doi.org\/10.1080\/17425247.2018.1522301.","journal-title":"Expert Opin Drug Deliv"},{"key":"1542_CR113","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s13346-016-0282-2","volume":"7","author":"MJ Mistilis","year":"2017","unstructured":"Mistilis MJ, Joyce JC, Esser ES, Skountzou I, Compans RW, Bommarius AS, et al. Long-term stability of influenza vaccine in a dissolving microneedle patch. Drug Deliv Transl Res. 2017;7:195\u2013205. https:\/\/doi.org\/10.1007\/s13346-016-0282-2.","journal-title":"Drug Deliv Transl Res"},{"key":"1542_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0272169","volume":"17","author":"DA Castilla-Casadiego","year":"2022","unstructured":"Castilla-Casadiego DA, Miranda-Mu\u00f1oz KA, Roberts JL, Crowell AD, Gonzalez-Nino D, Choudhury D, et al. Biodegradable microneedle patch for delivery of meloxicam for managing pain in cattle. PLoS ONE. 2022;17:1\u201319. https:\/\/doi.org\/10.1371\/journal.pone.0272169.","journal-title":"PLoS ONE"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01542-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01542-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01542-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T15:11:19Z","timestamp":1729696279000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01542-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":114,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1542"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01542-9","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"7 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University Valencia (2023-VSC-PEA-0064).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}